Tunlametinib is a pharmaceutical drug for the treatment of cancer. It is an inhibitor of mitogen-activated protein kinase kinase.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.